| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10695 | 2021 |
| A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications Z Sheng, L Li, LJ Zhu, TW Smith, A Demers, AH Ross, RP Moser, ... Nature medicine 16 (6), 671-677, 2010 | 190 | 2010 |
| Connexin 43 inhibition sensitizes chemoresistant glioblastoma cells to temozolomide SF Murphy, RT Varghese, S Lamouille, S Guo, KJ Pridham, P Kanabur, ... Cancer research 76 (1), 139-149, 2016 | 146 | 2016 |
| A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications S Guo, Y Liang, SF Murphy, A Huang, H Shen, DF Kelly, P Sobrado, ... Autophagy 11 (3), 560-572, 2015 | 146 | 2015 |
| BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription Z Sheng, L Ma, JE Sun, LJ Zhu, MR Green Blood, The Journal of the American Society of Hematology 118 (10), 2840-2848, 2011 | 146 | 2011 |
| A therapeutically targetable mechanism of BCR-ABL–independent imatinib resistance in chronic myeloid leukemia L Ma, Y Shan, R Bai, L Xue, CA Eide, J Ou, LJ Zhu, L Hutchinson, J Cerny, ... Science translational medicine 6 (252), 252ra121-252ra121, 2014 | 138 | 2014 |
| Nuclear and nucleolar localization of 18-kDa fibroblast growth factor-2 is controlled by C-terminal signals Z Sheng, JA Lewis, WJ Chirico Journal of Biological Chemistry 279 (38), 40153-40160, 2004 | 103 | 2004 |
| A new interleukin-13 amino-coated gadolinium metallofullerene nanoparticle for targeted MRI detection of glioblastoma tumor cells T Li, S Murphy, B Kiselev, KS Bakshi, J Zhang, A Eltahir, Y Zhang, Y Chen, ... Journal of the American Chemical Society 137 (24), 7881-7888, 2015 | 86 | 2015 |
| The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells H Zhang, C Peng, Y Hu, H Li, Z Sheng, Y Chen, C Sullivan, J Cerny, ... Nature genetics 44 (8), 861-871, 2012 | 84 | 2012 |
| Real-time visualization of nanoparticles interacting with glioblastoma stem cells ES Pohlmann, K Patel, S Guo, MJ Dukes, Z Sheng, DF Kelly Nano letters 15 (4), 2329-2335, 2015 | 62 | 2015 |
| Survival kinase genes present prognostic significance in glioblastoma RT Varghese, Y Liang, T Guan, CT Franck, DF Kelly, Z Sheng Oncotarget 7 (15), 20140, 2016 | 59 | 2016 |
| Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics CL Grek, Z Sheng, CC Naus, WC Sin, RG Gourdie, GG Ghatnekar Current opinion in pharmacology 41, 79-88, 2018 | 58 | 2018 |
| Direct regulation of rRNA transcription by fibroblast growth factor 2 Z Sheng, Y Liang, CY Lin, L Comai, WJ Chirico Molecular and cellular biology 25 (21), 9419-9426, 2005 | 56 | 2005 |
| PIK3CB/p110β is a selective survival factor for glioblastoma KJ Pridham, L Le, S Guo, RT Varghese, S Algino, Y Liang, R Fajardin, ... Neuro-oncology 20 (4), 494-505, 2018 | 48 | 2018 |
| Transcription and signalling pathways involved in BCR–ABL‐mediated misregulation of 24p3 and 24p3R Z Sheng, SZ Wang, MR Green The EMBO Journal 28 (7), 866-876, 2009 | 47 | 2009 |
| A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas RB Den, M Kamrava, Z Sheng, M Werner-Wasik, E Dougherty, ... International Journal of Radiation Oncology* Biology* Physics 85 (2), 321-328, 2013 | 46 | 2013 |
| Development of PLGA nanoparticles for sustained release of a connexin43 mimetic peptide to target glioblastoma cells R Roberts, JW Smyth, J Will, P Roberts, CL Grek, GS Ghatnekar, Z Sheng, ... Materials Science and Engineering: C 108, 110191, 2020 | 41 | 2020 |
| Patient-derived glioblastoma stem cells respond differentially to targeted therapies P Kanabur, S Guo, CM Rodgers, GR Simonds, DF Kelly, RG Gourdie, ... Oncotarget 7 (52), 86406, 2016 | 36 | 2016 |
| An activating transcription factor 5-mediated survival pathway as a target for cancer therapy Z Sheng, SK Evans, MR Green Oncotarget 1 (6), 457, 2010 | 34 | 2010 |
| hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene HK Oh, E Lee, HN Jang, J Lee, H Moon, Z Sheng, Y Jun, TJ Loh, S Cho, ... Apoptosis 18, 825-835, 2013 | 33 | 2013 |
Kevin J Pridham, Ph.D.Postdoctoral Research Associate, Virginia TechVerified email at vt.edu
